Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
Clinical trial NCT05514340 · RECRUITING
Trial details
- NCT number
- NCT05514340
- Sponsor
- Pharmazz, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-06
- Primary completion
- 2026-11-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.